Discover 1,839 paid clinical trials in Lakeland, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,839
Galleri® in the Medicare Population.
for
Cancer
Location: Tampa FL, Augusta GA, Atlanta GA, Marrero LA,
Sponsor: GRAIL, Inc.
Sex: All
Age: 50+
Code: NCT05673018
Recruiting
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Location: Tampa FL, Houston TX, Columbus OH, Philadelphia PA,
Sponsor: Arcellx, Inc.
Sex: All
Age: 18+
Code: NCT06626919
Phase1, Recruiting
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
for
Myasthenia Gravis
Location: Tampa FL, Hershey PA, Philadelphia PA, Ann Arbor MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 2 - 17
Code: NCT05265273
Phase2, Phase3, Recruiting
Pharmacist-Led Continuous Glucose Monitoring for Prediabetes
for
Prediabetes
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 18 - 70
Code: NCT07529366
Recruiting
An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia
for
Friedreich Ataxia
Location: Tampa FL, Chevy Chase MD, Philadelphia PA, Eatontown NJ,
Sponsor: Larimar Therapeutics, Inc.
Sex: All
Age: 2 - 60
Code: NCT06447025
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Tampa FL, Miami FL, Stamford CT, Lebanon NH, El Paso TX
Sponsor: Kedrion S.p.A.
Sex: All
Age: 18+
Code: NCT06752356
Phase3, Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
for
Myotonic Dystrophy
Location: Tampa FL, Gainesville FL, Richmond VA, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 10 - 55
Code: NCT06844214
Phase1, Phase2, Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
for
Chronic Migraine in Children
Location: Tampa FL, Hialeah FL, Gulf Breeze FL, Norfolk VA,
Sponsor: H. Lundbeck A/S
Sex: All
Age: 12 - 17
Code: NCT04965675
Phase3, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Tampa FL, Jacksonville FL, Miami FL, Atlanta GA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: Tampa FL, Jacksonville FL, Boynton Beach FL,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase3, Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis
Location: Tampa FL, Clearwater FL, Maitland FL, Bradenton FL,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07299019
Phase3, Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
for
Multiple Sclerosis (MS) Primary Progressive
Location: Tampa FL, Maitland FL, Bradenton FL, Greenville SC,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07067463
Phase3, Recruiting
Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID)
for
Hearing Loss, Conductive, Hearing Loss, Mixed,
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 18 - 70+
Code: NCT04899037
Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: Tampa FL, Mt. Pleasant SC, Columbia SC, Atlanta GA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase3, Recruiting
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
for
Neurotrophic Keratopathy
Location: Tampa FL, Crystal River FL, Miami FL, Sandy Springs GA,
Sponsor: ReGenTree, LLC
Sex: All
Age: 18+
Code: NCT05555589
Phase3, Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
for
Amblyopia
Location: Tampa FL, Fort Lauderdale FL, Mt. Pleasant SC,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 8 - 12
Code: NCT06524882
Phase3, Recruiting
Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency